Market News AIOpen the app

MAIA stock news · MAIA Biotechnology, Inc.

Stories about MAIA Biotechnology, Inc. (MAIA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for MAIA

Follow MAIA Biotechnology, Inc. (MAIA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MAIA
Free on the App Store and Google Play, or on the web.
  1. Nov 17, 2026, 9:02 AM ET · Trial

    MAIA Biotechnology shared promising results from its Phase 2 study on a new lung cancer treatment.

    Good for MAIA

    MAIA reported an 88% disease control rate in its expanded Phase 2 THIO-101 study. Results matching earlier parts favor MAIA, though the study is ongoing.

  2. Oct 6, 2026, 8:26 AM ET · Market

    MAIA Biotechnology, Inc. shares new information about its business plans.

    Neutral

    MAIA posted a presentation and summary, but this filing gives no new trial or sales results. It does not change the company's outlook.